Create a super aesthetic, handwritten-style revision note page for the topic: [Hypertension]. Make it look like neat exam notes written on a page (top view, clean layout, colorful headings, underlines, boxes). Keep it crisp, high-yield, and exam-oriented. Use clear headings and organize content like this (modify if needed for topic): Definition Etiology Pathogenesis (flow/arrow style) Clinical features Key features Differential diagnosis Management Complications Key points / last-minute revision box Add simple diagrams or labeled sketches wherever helpful. Highlight important keywords. Include one memory trick / one-line summary Keep handwriting-style fonts, pastel colors, and clean spacing
ls /home/daytona/workspace/ 2>/dev/null || echo "workspace empty or does not exist"
~/hypertension-notes/hypertension_notes.html
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Hypertension – Revision Notes</title>
<link href="https://fonts.googleapis.com/css2?family=Caveat:wght@400;600;700&family=Patrick+Hand&family=Kalam:wght@300;400;700&display=swap" rel="stylesheet">
<style>
* { margin: 0; padding: 0; box-sizing: border-box; }
body {
background: #f0ece3;
font-family: 'Kalam', cursive;
padding: 30px 20px;
min-height: 100vh;
}
.page {
background: #fffdf5;
max-width: 960px;
margin: 0 auto;
padding: 50px 55px 60px 80px;
border-radius: 4px;
box-shadow: 3px 3px 20px rgba(0,0,0,0.15), -1px -1px 6px rgba(0,0,0,0.05);
position: relative;
/* ruled lines */
background-image:
linear-gradient(#e8e0d0 1px, transparent 1px),
linear-gradient(90deg, #f5a0a0 1px, transparent 1px);
background-size: 36px 36px, 100% 100%;
background-position: 0 68px, 62px 0;
}
/* Red margin line */
.page::before {
content: '';
position: absolute;
top: 0; left: 62px;
width: 2px;
height: 100%;
background: #f5a0a0;
border-radius: 1px;
}
/* Spiral holes */
.holes {
position: absolute;
top: 30px; left: -18px;
display: flex;
flex-direction: column;
gap: 60px;
}
.hole {
width: 22px; height: 22px;
background: #f0ece3;
border-radius: 50%;
border: 2px solid #ccc;
box-shadow: inset 1px 1px 3px rgba(0,0,0,0.15);
}
/* ── Title ── */
.page-title {
font-family: 'Caveat', cursive;
font-size: 42px;
font-weight: 700;
color: #2c3e6b;
text-align: center;
margin-bottom: 4px;
letter-spacing: 1px;
text-decoration: underline;
text-decoration-color: #7fb3f5;
text-decoration-thickness: 3px;
}
.page-subtitle {
font-family: 'Kalam', cursive;
font-size: 14px;
color: #888;
text-align: center;
margin-bottom: 28px;
}
/* ── Section headings ── */
.section-heading {
font-family: 'Caveat', cursive;
font-size: 22px;
font-weight: 700;
display: inline-block;
padding: 3px 14px 3px 10px;
border-radius: 4px;
margin-bottom: 10px;
margin-top: 4px;
letter-spacing: 0.5px;
}
.h-blue { background: #dbeeff; color: #1a5fa8; border-left: 4px solid #4a9ef5; }
.h-pink { background: #ffe0ec; color: #b0185a; border-left: 4px solid #f06292; }
.h-green { background: #d6f5e3; color: #1a7a40; border-left: 4px solid #4caf7d; }
.h-yellow { background: #fff3cc; color: #8a6200; border-left: 4px solid #f5c518; }
.h-purple { background: #ede0ff; color: #5a1a9a; border-left: 4px solid #9c64f5; }
.h-orange { background: #ffe8d5; color: #a03a00; border-left: 4px solid #f57c45; }
.h-teal { background: #d5f5f5; color: #006060; border-left: 4px solid #40c0c0; }
.h-red { background: #fde0e0; color: #900; border-left: 4px solid #e55; }
/* ── Content text ── */
.content { font-size: 15px; color: #333; line-height: 1.75; margin-bottom: 6px; }
.content ul { padding-left: 20px; }
.content ul li { margin-bottom: 3px; }
.content ul li::marker { color: #aaa; }
/* ── Highlight ── */
.hl-yellow { background: #fff176; padding: 0 3px; border-radius: 3px; font-weight: 600; }
.hl-pink { background: #ffc1d8; padding: 0 3px; border-radius: 3px; font-weight: 600; }
.hl-blue { background: #b3d9ff; padding: 0 3px; border-radius: 3px; font-weight: 600; }
.hl-green { background: #b8f0cd; padding: 0 3px; border-radius: 3px; font-weight: 600; }
.hl-orange { background: #ffd199; padding: 0 3px; border-radius: 3px; font-weight: 600; }
/* ── Divider ── */
.divider {
border: none;
border-top: 1.5px dashed #ccc;
margin: 18px 0 14px 0;
}
/* ── Two-column layout ── */
.two-col { display: grid; grid-template-columns: 1fr 1fr; gap: 20px; margin-bottom: 0; }
.three-col { display: grid; grid-template-columns: 1fr 1fr 1fr; gap: 16px; margin-bottom: 0; }
/* ── Box / Card ── */
.box {
border-radius: 8px;
padding: 12px 14px;
margin-bottom: 12px;
}
.box-blue { background: #eaf4ff; border: 1.5px solid #7ab8f5; }
.box-pink { background: #fff0f5; border: 1.5px solid #f5a0c0; }
.box-green { background: #eafaf0; border: 1.5px solid #6dcc95; }
.box-yellow { background: #fffaeb; border: 1.5px solid #f5d060; }
.box-purple { background: #f5eeff; border: 1.5px solid #b08ae0; }
.box-orange { background: #fff6ee; border: 1.5px solid #f5a060; }
.box-red { background: #fff0f0; border: 2px solid #e55; }
.box-teal { background: #eafafa; border: 1.5px solid #60c0c0; }
.box-title {
font-family: 'Caveat', cursive;
font-size: 16px;
font-weight: 700;
margin-bottom: 6px;
}
/* ── Arrow flow ── */
.flow {
display: flex;
flex-wrap: wrap;
align-items: center;
gap: 4px;
font-size: 14px;
color: #333;
margin: 6px 0;
line-height: 1.5;
}
.flow-step {
background: #fff;
border: 1.5px solid #aaa;
border-radius: 6px;
padding: 4px 10px;
font-size: 13.5px;
white-space: nowrap;
}
.flow-step.blue { border-color: #4a9ef5; background: #eaf4ff; }
.flow-step.pink { border-color: #f06292; background: #fff0f5; }
.flow-step.green { border-color: #4caf7d; background: #eafaf0; }
.flow-step.yellow { border-color: #f5c518; background: #fffaeb; }
.flow-step.orange { border-color: #f57c45; background: #fff6ee; }
.flow-step.purple { border-color: #9c64f5; background: #f5eeff; }
.flow-step.red { border-color: #e55; background: #fff0f0; }
.arrow { font-size: 18px; color: #888; line-height: 1; }
/* ── Table ── */
table.notes-table {
width: 100%;
border-collapse: collapse;
font-size: 14px;
margin: 8px 0;
}
table.notes-table th {
background: #dbeeff;
color: #1a5fa8;
font-family: 'Caveat', cursive;
font-size: 16px;
padding: 6px 10px;
border: 1.5px solid #9ec8f5;
text-align: left;
}
table.notes-table td {
padding: 5px 10px;
border: 1px solid #d0d8e8;
vertical-align: top;
}
table.notes-table tr:nth-child(even) td { background: #f5f9ff; }
/* ── Mnemonic / memory box ── */
.mnemonic-box {
background: linear-gradient(135deg, #fff9e6, #fff0fa);
border: 2px dashed #f0b040;
border-radius: 10px;
padding: 14px 18px;
margin: 14px 0 8px 0;
position: relative;
}
.mnemonic-box .star {
position: absolute;
top: -12px; left: 14px;
font-size: 22px;
}
.mnemonic-title {
font-family: 'Caveat', cursive;
font-size: 17px;
font-weight: 700;
color: #c07000;
margin-bottom: 5px;
}
/* ── Last-minute revision box ── */
.lastmin-box {
background: linear-gradient(135deg, #fff0f5, #f0f5ff);
border: 2.5px solid #d060a0;
border-radius: 10px;
padding: 16px 20px;
margin-top: 16px;
}
.lastmin-title {
font-family: 'Caveat', cursive;
font-size: 20px;
font-weight: 700;
color: #c0105a;
margin-bottom: 10px;
display: flex;
align-items: center;
gap: 6px;
}
.lastmin-box ul { padding-left: 20px; }
.lastmin-box li { margin-bottom: 5px; font-size: 14.5px; }
/* ── Sketch/diagram ── */
.sketch {
font-family: 'Kalam', cursive;
font-size: 13px;
color: #444;
text-align: center;
margin: 8px 0;
}
.sketch svg { display: block; margin: 0 auto; }
/* ── Tag pills ── */
.tag {
display: inline-block;
border-radius: 20px;
padding: 2px 10px;
font-size: 12.5px;
margin: 2px 3px 2px 0;
font-family: 'Kalam', cursive;
}
.tag-blue { background: #dbeeff; color: #1a5fa8; border: 1px solid #7ab8f5; }
.tag-pink { background: #ffe0ec; color: #b0185a; border: 1px solid #f06292; }
.tag-green { background: #d6f5e3; color: #1a7a40; border: 1px solid #4caf7d; }
.tag-orange { background: #ffe8d5; color: #a03a00; border: 1px solid #f57c45; }
.tag-red { background: #fde0e0; color: #900; border: 1px solid #e55; }
/* underline decoration */
.underline-blue { border-bottom: 2.5px solid #4a9ef5; display: inline; }
.underline-pink { border-bottom: 2.5px solid #f06292; display: inline; }
.underline-green { border-bottom: 2.5px solid #4caf7d; display: inline; }
/* small note */
.note-sm { font-size: 12.5px; color: #888; font-style: italic; }
/* section gap */
.sec { margin-bottom: 22px; }
/* dotted separator */
.dot-sep { color: #ccc; font-size: 20px; margin: 0 5px; }
</style>
</head>
<body>
<div class="page">
<!-- spiral holes -->
<div class="holes">
<div class="hole"></div><div class="hole"></div><div class="hole"></div>
<div class="hole"></div><div class="hole"></div><div class="hole"></div>
<div class="hole"></div><div class="hole"></div><div class="hole"></div>
<div class="hole"></div><div class="hole"></div><div class="hole"></div>
</div>
<!-- ═══ TITLE ═══ -->
<div class="page-title">🩺 Hypertension</div>
<div class="page-subtitle">High-Yield Exam Notes · Internal Medicine / Pharmacology · 2025–26</div>
<hr class="divider">
<!-- ═══ 1. DEFINITION ═══ -->
<div class="sec">
<div class="section-heading h-blue">① Definition</div>
<div class="content">
Sustained elevation of arterial blood pressure ≥ <span class="hl-yellow">130/80 mmHg</span> (2017 ACC/AHA guideline).
<br>
<span class="note-sm">Previously: ≥ 140/90 mmHg (JNC-7). Know <em>both</em> for exams!</span>
</div>
<!-- BP classification table -->
<table class="notes-table" style="margin-top:10px;">
<tr>
<th>Category</th><th>Systolic (mmHg)</th><th>Diastolic (mmHg)</th>
</tr>
<tr><td>Normal</td><td>< 120</td><td>< 80</td></tr>
<tr><td><span class="hl-green">Elevated</span></td><td>120–129</td><td>< 80</td></tr>
<tr><td><span class="hl-yellow">Stage I HTN</span></td><td>130–139</td><td>80–89</td></tr>
<tr><td><span class="hl-orange">Stage II HTN</span></td><td>≥ 140</td><td>≥ 90</td></tr>
<tr><td><span class="hl-pink">Hypertensive Crisis</span></td><td>≥ 180</td><td>≥ 120</td></tr>
</table>
<div class="note-sm" style="margin-top:4px;">* CVD risk doubles with every ↑ 20/10 mmHg above 115/75 mmHg</div>
</div>
<hr class="divider">
<!-- ═══ 2. ETIOLOGY ═══ -->
<div class="sec">
<div class="section-heading h-pink">② Etiology</div>
<div class="two-col">
<div class="box box-pink">
<div class="box-title" style="color:#b0185a;">🔵 Primary / Essential HTN</div>
<div class="content">
<ul>
<li><span class="hl-pink">90–95%</span> of all cases</li>
<li>Multifactorial – genetic + environmental</li>
<li>No single identifiable cause</li>
<li>Risk factors: age, obesity, ↑ salt, alcohol, smoking, family Hx, sedentary lifestyle, stress</li>
<li>Heritability ~<span class="hl-yellow">30%</span></li>
</ul>
</div>
</div>
<div class="box box-blue">
<div class="box-title" style="color:#1a5fa8;">🔴 Secondary HTN (~5–10%)</div>
<div class="content">
<ul>
<li><b>Renal:</b> RAS, glomerulonephritis, polycystic kidney, renal vasculitis</li>
<li><b>Endocrine:</b> <span class="hl-yellow">Conn's</span> (1° aldosteronism), <span class="hl-pink">phaeochromocytoma</span>, Cushing's, hyperthyroidism, acromegaly</li>
<li><b>Cardiovascular:</b> Coarctation of aorta</li>
<li><b>Drugs:</b> OCP, NSAIDs, steroids, sympathomimetics</li>
<li><b>Sleep apnea</b></li>
<li><b>Pregnancy:</b> Preeclampsia</li>
</ul>
</div>
</div>
</div>
<div class="sketch" style="margin-top:4px;">
<span class="tag tag-orange">⚡ Clue to 2° HTN:</span>
Young pt, resistant to ≥3 drugs, hypokalaemia, headache/palpitation episodes → investigate!
</div>
</div>
<hr class="divider">
<!-- ═══ 3. PATHOGENESIS ═══ -->
<div class="sec">
<div class="section-heading h-green">③ Pathogenesis (Flow)</div>
<div class="content note-sm" style="margin-bottom:8px;">BP = CO × PVR | ↑ BP = ↑ CO and/or ↑ PVR</div>
<!-- RAAS pathway -->
<div style="font-family:'Caveat',cursive; font-size:14px; color:#1a7a40; font-weight:700; margin-bottom:4px;">RAAS Pathway →</div>
<div class="flow">
<div class="flow-step blue">↓ Renal Perfusion</div><div class="arrow">→</div>
<div class="flow-step blue">Renin ↑ (JGA)</div><div class="arrow">→</div>
<div class="flow-step green">Angiotensinogen → Ang I</div><div class="arrow">→</div>
<div class="flow-step green">ACE (lung) → <span class="hl-green">Ang II</span></div><div class="arrow">→</div>
<div class="flow-step yellow">Vasoconstriction ↑ PVR</div>
<br>
<div class="flow-step orange">Ang II → Adrenal Cortex</div><div class="arrow">→</div>
<div class="flow-step orange">Aldosterone ↑</div><div class="arrow">→</div>
<div class="flow-step red">Na⁺ & H₂O retention ↑</div><div class="arrow">→</div>
<div class="flow-step red">↑ CO → ↑ BP</div>
</div>
<!-- SNS pathway -->
<div style="font-family:'Caveat',cursive; font-size:14px; color:#b0185a; font-weight:700; margin-top:10px; margin-bottom:4px;">SNS Activation →</div>
<div class="flow">
<div class="flow-step pink">Stress / Obesity</div><div class="arrow">→</div>
<div class="flow-step pink">↑ SNS activity</div><div class="arrow">→</div>
<div class="flow-step pink">↑ HR, ↑ contractility</div><div class="arrow">→</div>
<div class="flow-step red">↑ CO</div>
</div>
<div class="flow">
<div class="flow-step pink">↑ Renal SNS</div><div class="arrow">→</div>
<div class="flow-step orange">↑ Na⁺ retention</div><div class="arrow">→</div>
<div class="flow-step orange">↑ Renin secretion</div><div class="arrow">→</div>
<div class="flow-step red">↑ RAAS cascade</div>
</div>
<!-- Vascular remodelling -->
<div style="font-family:'Caveat',cursive; font-size:14px; color:#5a1a9a; font-weight:700; margin-top:10px; margin-bottom:4px;">Vascular Remodelling (chronic) →</div>
<div class="flow">
<div class="flow-step purple">↑ Ang II + Endothelin-1</div><div class="arrow">→</div>
<div class="flow-step purple">Smooth muscle hypertrophy</div><div class="arrow">→</div>
<div class="flow-step purple">↑ PVR</div><div class="arrow">→</div>
<div class="flow-step red">Sustained ↑ BP</div>
</div>
<div class="note-sm" style="margin-top:6px;">↓ Nitric oxide (vasodilator) + ↑ Endothelin-1 (vasoconstrictor) = endothelial dysfunction</div>
</div>
<hr class="divider">
<!-- ═══ 4. CLINICAL FEATURES ═══ -->
<div class="sec">
<div class="section-heading h-yellow">④ Clinical Features</div>
<div class="two-col">
<div class="box box-yellow">
<div class="box-title" style="color:#8a6200;">😐 Usually Asymptomatic!</div>
<div class="content">
<ul>
<li>Called the <span class="hl-yellow">"Silent Killer"</span></li>
<li>Detected on routine BP check</li>
<li>Headache (occipital, morning) — <em>late sign</em></li>
<li>Dizziness / blurred vision</li>
<li>Epistaxis (nosebleed)</li>
<li>Tinnitus, palpitations</li>
</ul>
</div>
</div>
<div class="box box-red">
<div class="box-title" style="color:#900;">🚨 Hypertensive Emergency Signs</div>
<div class="content">
<ul>
<li>BP ≥ <span class="hl-pink">180/120</span> mmHg + end-organ damage</li>
<li>Encephalopathy / altered consciousness</li>
<li>Papilledema (optic disc swelling)</li>
<li>Acute heart failure / pulmonary oedema</li>
<li>AKI (haematuria, ↑ Cr)</li>
<li>Aortic dissection</li>
<li>Seizures</li>
</ul>
</div>
</div>
</div>
<div class="content" style="margin-top:4px;">
<b>Exam findings:</b>
<span class="tag tag-blue">LVH on ECG</span>
<span class="tag tag-blue">S4 gallop</span>
<span class="tag tag-blue">Fundoscopy: AV nipping, silver wiring, flame haemorrhages</span>
<span class="tag tag-pink">Renal bruits (RAS)</span>
</div>
</div>
<hr class="divider">
<!-- ═══ 5. KEY FEATURES / DIAGNOSIS ═══ -->
<div class="sec">
<div class="section-heading h-teal">⑤ Key Features & Diagnosis</div>
<div class="two-col">
<div class="content">
<b>How to diagnose:</b>
<ul>
<li>≥ 2 readings on ≥ 2 occasions</li>
<li><span class="hl-blue">ABPM</span> (ambulatory BP monitoring) — gold standard to exclude white-coat HTN</li>
<li><span class="hl-blue">HBPM</span> (home BP monitoring) — acceptable alternative</li>
<li>Both arms measured; use higher reading</li>
</ul>
<br>
<b>Workup:</b>
<ul>
<li>U&E, Cr, eGFR (renal function)</li>
<li>Fasting glucose + lipids</li>
<li>Urinalysis (protein, RBCs)</li>
<li>ECG (LVH, arrhythmia)</li>
<li>Fundoscopy</li>
<li>Echo if LVH suspected</li>
</ul>
</div>
<!-- Sketch: fundoscopy grades -->
<div class="box box-teal" style="font-size:13.5px;">
<div class="box-title" style="color:#006060;">👁 Keith-Wagener-Barker (Fundoscopy) Grades</div>
<table style="width:100%; font-size:12.5px; border-collapse:collapse;">
<tr style="background:#d5f5f5;"><th style="padding:3px 6px; border:1px solid #aaa;">Grade</th><th style="padding:3px 6px; border:1px solid #aaa;">Finding</th></tr>
<tr><td style="padding:3px 6px; border:1px solid #ddd;">I</td><td style="padding:3px 6px; border:1px solid #ddd;">Silver wiring of arterioles</td></tr>
<tr><td style="padding:3px 6px; border:1px solid #ddd;">II</td><td style="padding:3px 6px; border:1px solid #ddd;">AV nipping (nicking)</td></tr>
<tr><td style="padding:3px 6px; border:1px solid #ddd;">III</td><td style="padding:3px 6px; border:1px solid #ddd;"><span class="hl-orange">Flame haemorrhages + Cotton-wool spots</span></td></tr>
<tr><td style="padding:3px 6px; border:1px solid #ddd;">IV</td><td style="padding:3px 6px; border:1px solid #ddd;"><span class="hl-pink">Papilledema</span> → Malignant HTN!</td></tr>
</table>
</div>
</div>
</div>
<hr class="divider">
<!-- ═══ 6. DIFFERENTIAL DIAGNOSIS ═══ -->
<div class="sec">
<div class="section-heading h-purple">⑥ Differential Diagnosis</div>
<div class="three-col">
<div class="box box-purple">
<div class="box-title" style="color:#5a1a9a;">🧪 Renal</div>
<div class="content" style="font-size:13.5px;">
<ul>
<li>Renal artery stenosis</li>
<li>Chronic kidney disease</li>
<li>Polycystic kidney disease</li>
<li>Glomerulonephritis</li>
</ul>
</div>
</div>
<div class="box box-orange">
<div class="box-title" style="color:#a03a00;">⚗️ Endocrine</div>
<div class="content" style="font-size:13.5px;">
<ul>
<li>Primary hyperaldosteronism (Conn's)</li>
<li>Phaeochromocytoma</li>
<li>Cushing's syndrome</li>
<li>Hyperthyroidism</li>
<li>Acromegaly</li>
</ul>
</div>
</div>
<div class="box box-pink">
<div class="box-title" style="color:#b0185a;">💊 Other</div>
<div class="content" style="font-size:13.5px;">
<ul>
<li>Coarctation of aorta</li>
<li>Preeclampsia</li>
<li>Obstructive sleep apnoea</li>
<li>Drug-induced (OCP, NSAIDs)</li>
<li>White-coat HTN</li>
</ul>
</div>
</div>
</div>
</div>
<hr class="divider">
<!-- ═══ 7. MANAGEMENT ═══ -->
<div class="sec">
<div class="section-heading h-orange">⑦ Management</div>
<!-- Lifestyle -->
<div class="box box-green" style="margin-bottom:10px;">
<div class="box-title" style="color:#1a7a40;">🏃 Step 1 — Lifestyle Modifications (ALL patients)</div>
<div class="content" style="font-size:13.5px;">
<span class="tag tag-green">↓ Salt (<6g/day)</span>
<span class="tag tag-green">DASH diet</span>
<span class="tag tag-green">Exercise ≥30 min/day</span>
<span class="tag tag-green">↓ Alcohol</span>
<span class="tag tag-green">Stop smoking</span>
<span class="tag tag-green">Weight loss</span>
<span class="tag tag-green">↓ Stress</span>
</div>
</div>
<!-- Drug therapy table -->
<div class="box box-blue">
<div class="box-title" style="color:#1a5fa8;">💊 Step 2 — Pharmacotherapy</div>
<table class="notes-table">
<tr>
<th>Class</th><th>Drug Example</th><th>1st Line For</th><th>Avoid In</th>
</tr>
<tr>
<td><span class="hl-blue">ACE inhibitor</span></td>
<td>Ramipril, Enalapril</td>
<td>DM, CKD, post-MI, HF</td>
<td>Pregnancy, bilateral RAS, hyperkalaemia</td>
</tr>
<tr>
<td><span class="hl-blue">ARB</span></td>
<td>Losartan, Valsartan</td>
<td>ACEi-intolerant (dry cough)</td>
<td>Pregnancy, bilateral RAS</td>
</tr>
<tr>
<td><span class="hl-green">CCB</span> (dihydropyridine)</td>
<td>Amlodipine, Nifedipine</td>
<td>Elderly, isolated systolic, angina</td>
<td>HF with reduced EF</td>
</tr>
<tr>
<td><span class="hl-yellow">Thiazide diuretic</span></td>
<td>Chlorthalidone, HCTZ</td>
<td>Elderly, osteoporosis, Black pts</td>
<td>Gout, hyponatraemia</td>
</tr>
<tr>
<td><span class="hl-pink">β-blocker</span></td>
<td>Atenolol, Carvedilol</td>
<td>Post-MI, HF, arrhythmia, angina</td>
<td>Asthma, COPD, heart block</td>
</tr>
<tr>
<td><span class="hl-orange">Aldosterone antag.</span></td>
<td>Spironolactone</td>
<td>Resistant HTN, HF</td>
<td>Hyperkalaemia, CKD severe</td>
</tr>
</table>
</div>
<!-- Step-up -->
<div style="margin-top:10px;">
<div style="font-family:'Caveat',cursive; font-size:15px; font-weight:700; color:#a03a00; margin-bottom:5px;">📋 AHA/ACC Step-Up Approach:</div>
<div class="flow">
<div class="flow-step green">Lifestyle ×3–6 months</div><div class="arrow">→</div>
<div class="flow-step blue">1 drug (ACEi / ARB / CCB / Thiazide)</div><div class="arrow">→</div>
<div class="flow-step yellow">2 drugs (combination)</div><div class="arrow">→</div>
<div class="flow-step orange">3 drugs (triple combo)</div><div class="arrow">→</div>
<div class="flow-step red">Resistant HTN → add Spironolactone / refer</div>
</div>
</div>
<!-- Target BPs -->
<div class="box box-yellow" style="margin-top:10px; font-size:13.5px;">
<div class="box-title" style="color:#8a6200;">🎯 BP Targets</div>
General: <span class="hl-yellow"><130/80</span> |
CKD + proteinuria: <span class="hl-orange"><125/75</span> |
Elderly (≥65): <span class="hl-green"><130/80</span> |
Pregnancy: <span class="hl-pink"><140/90</span>
</div>
<!-- Hypertensive emergency -->
<div class="box box-red" style="margin-top:10px; font-size:13.5px;">
<div class="box-title" style="color:#900;">🚨 Hypertensive Emergency Tx</div>
IV labetalol / nicardipine / sodium nitroprusside |
<span class="hl-pink">Reduce MAP by ≤ 25% in 1st hour</span>, then to 160/100 over next 2–6h
<br>Do NOT lower BP too fast → cerebral hypoperfusion!
</div>
</div>
<hr class="divider">
<!-- ═══ 8. COMPLICATIONS ═══ -->
<div class="sec">
<div class="section-heading h-red">⑧ Complications — "CHASED"</div>
<div class="three-col">
<div class="box box-red">
<div class="box-title" style="color:#900;">💔 Cardiac</div>
<div class="content" style="font-size:13.5px;">
<ul>
<li>LVH → diastolic HF</li>
<li>Ischaemic heart disease / MI</li>
<li>Atrial fibrillation</li>
</ul>
</div>
</div>
<div class="box box-orange">
<div class="box-title" style="color:#a03a00;">🧠 Neuro</div>
<div class="content" style="font-size:13.5px;">
<ul>
<li>Ischaemic stroke</li>
<li>Haemorrhagic stroke</li>
<li>Multi-infarct dementia</li>
<li>Hypertensive encephalopathy</li>
</ul>
</div>
</div>
<div class="box box-blue">
<div class="box-title" style="color:#1a5fa8;">🫘 Renal</div>
<div class="content" style="font-size:13.5px;">
<ul>
<li>Nephrosclerosis → CKD</li>
<li>Proteinuria / haematuria</li>
<li>ESRD</li>
</ul>
</div>
</div>
</div>
<div class="two-col" style="margin-top:10px;">
<div class="box box-purple">
<div class="box-title" style="color:#5a1a9a;">👁 Ocular</div>
<div class="content" style="font-size:13.5px;">
Hypertensive retinopathy (Grades I–IV)<br>
Retinal vein/artery occlusion
</div>
</div>
<div class="box box-yellow">
<div class="box-title" style="color:#8a6200;">🩸 Vascular</div>
<div class="content" style="font-size:13.5px;">
Aortic dissection / aneurysm<br>
Peripheral arterial disease<br>
Accelerated atherosclerosis
</div>
</div>
</div>
<div style="text-align:center; margin-top:8px;">
<div style="font-family:'Caveat',cursive; font-size:16px; font-weight:700; color:#900; display:inline-block; background:#fde0e0; border:1.5px dashed #e55; padding:4px 18px; border-radius:6px;">
½ die of IHD/HF · ⅓ die of stroke · ↓ with treatment!
</div>
</div>
</div>
<hr class="divider">
<!-- ═══ 9. MNEMONIC ═══ -->
<div class="mnemonic-box">
<div class="star">⭐</div>
<div class="mnemonic-title">🧠 Memory Trick — 2° HTN: "CRASH & COPE"</div>
<div style="font-size:14px; color:#555; line-height:1.9;">
<b style="color:#c07000;">C</b>oarctation of aorta ·
<b style="color:#c07000;">R</b>eno-vascular (RAS) ·
<b style="color:#c07000;">A</b>ldosteronism (Conn's) ·
<b style="color:#c07000;">S</b>leep apnoea ·
<b style="color:#c07000;">H</b>yperthyroidism<br>
<b style="color:#c07000;">C</b>ushing's ·
<b style="color:#c07000;">O</b>besity / OCP ·
<b style="color:#c07000;">P</b>haeochromocytoma ·
<b style="color:#c07000;">E</b>clampsia (pre-)
</div>
<div style="margin-top:8px; font-size:13.5px; color:#a06000;">
<b>Antihypertensive mnemonic — "ABCD":</b>
<span class="hl-yellow">A</span>CEi/ARB →
<span class="hl-orange">B</span>eta-blocker →
<span class="hl-green">C</span>CB →
<span class="hl-blue">D</span>iuretic (thiazide)
</div>
</div>
<!-- ═══ 10. LAST-MINUTE REVISION BOX ═══ -->
<div class="lastmin-box">
<div class="lastmin-title">📌 Last-Minute Revision Box</div>
<ul>
<li>HTN = <span class="hl-pink">BP ≥ 130/80</span> (ACC/AHA 2017) or <span class="hl-yellow">≥ 140/90</span> (older JNC-7)</li>
<li><span class="hl-blue">Essential HTN (90–95%)</span> — polygenic, multifactorial, asymptomatic for years</li>
<li><span class="hl-orange">RAAS</span> and <span class="hl-orange">SNS activation</span> → core mechanisms; BP = CO × PVR</li>
<li>1st line drugs: <span class="hl-green">ACEi/ARB, CCB, Thiazide</span> (β-blocker only for specific indications)</li>
<li>DM + HTN → <span class="hl-blue">ACEi or ARB</span> (renoprotective)</li>
<li>Black patients → prefer <span class="hl-yellow">CCB or Thiazide</span> (ACEi less effective)</li>
<li>Malignant HTN → <span class="hl-pink">BP ≥ 180/120 + papilledema/end-organ damage</span> → emergency IV tx</li>
<li>Do NOT lower BP too fast in emergency — <span class="hl-orange">max ↓25% MAP in 1st hour</span></li>
<li>Complications: <span class="hl-pink">Stroke (⅓)</span>, <span class="hl-pink">IHD/HF (½)</span>, CKD, retinopathy, aortic dissection</li>
<li>ABPM = gold standard to exclude white-coat & masked hypertension</li>
</ul>
<div style="margin-top:12px; padding:10px 14px; background:#fff; border-radius:8px; border:1.5px dashed #d060a0; font-size:14.5px;">
<b style="color:#c0105a;">⚡ One-line Summary:</b>
Hypertension is the <em>"silent killer"</em> — a chronic, multifactorial elevation in BP (≥130/80 mmHg) driven by ↑ RAAS/SNS/PVR, managed with lifestyle + ABCD drugs, causing CHASED complications if untreated.
</div>
</div>
<div style="text-align:right; margin-top:16px; font-family:'Caveat',cursive; font-size:13px; color:#bbb;">
Sources: Katzung Basic & Clinical Pharmacology 16e · Robbins Pathology 10e · Fuster & Hurst's The Heart 15e · Harrison's 22e
</div>
</div>
</body>
</html>